News
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows ...
The insurer and plan administrator has accused providers and a billing service of flooding it with No Surprises Act disputes.
StockStory.org on MSN1d
Elevance Health (ELV): Buy, Sell, or Hold Post Q1 Earnings?Elevance Health has been in a holding pattern, floating around $383.92. Given the underwhelming price action, is now a good ...
Buying $1000 In ELV: If an investor had bought $1000 of ELV stock 15 years ago, it would be worth $6,891.46 today based on a price of $380.01 for ELV at the time of writing.
Hotchkis & Wiley, an investment management company, released its “Hotchkis & Wiley Large Cap Fundamental Value Fund” first ...
This was the stock's second consecutive day of losses.
Over the past year, many Elevance Health, Inc. ( NYSE:ELV ) insiders sold a significant stake in the company which ...
The 12-month price targets, analyzed by analysts, offer insights with an average target of $505.0, a high estimate of $529.00 ...
HaloMD, a billing dispute consulting company, is denying allegations leveled against it in a lawsuit filed by a subsidiary of ...
Elevance Health accuses Georgia providers of flooding the No Surprises Act independent dispute resolution system with ...
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action on behalf of purchasers of common ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results